Inhibition of DNA synthesis in rat hepatocytes by platelet-derived type β transforming growth factor

B. I. Carr, I. Hayashi, E. L. Branum, H. L. Moses

Research output: Contribution to journalArticle

268 Citations (Scopus)

Abstract

Platelet-derived type β transforming growth factor (TGFβ) is a potent inhibitor of DNA synthesis in primary monolayer cultures of adult rat hepatocytes. TGFβ induced a 50% inhibition of epidermal growth factor (EGF)-mediated DNA synthesis at approximately 5 x 1012 M. This inhibition did not appear to be due to a delay in the peak of DNA synthesis or a toxic action, nor could it be overcome by increasing concentrations of the mitogens EGF, insulin, or glucagon. Inhibition was observed either when TGFβ and EGF were continuously present together in the culture medium or when TGFβ was added to the hepatocyte cultures after removal of the EGF stimulant. This observation together with a lack of an inhibitory effect of TGFβ on the binding of 125I-labeled EGF to hepatocytes in culture, suggests that the inhibitory action of TGFβ was not caused by a direct competition with EGF at the cell surface. TGFβ could not inhibit DNA synthesis once it had begun; however, the inhibitory action of TGFβ could be partially overcome by increasing amounts of conditioned medium produced by normal hepatocytes. Specific saturable receptors for TGFβ were found on the normal rat hepatocytes, but specific binding could not be detected on hepatocytes from regenerating liver. TGFβ is thus a potent inhibitor of EGF-induced DNA synthesis in adult rat hepatocytes. Its significance for growth control in vivo has yet to be assessed.

Original languageEnglish
Pages (from-to)2330-2334
Number of pages5
JournalCancer Research
Volume46
Issue number5
Publication statusPublished - 1986

Fingerprint

Platelet-Derived Growth Factor
Transforming Growth Factors
Transforming Growth Factor beta
Hepatocytes
Epidermal Growth Factor
DNA
Nucleic Acid Synthesis Inhibitors
Toxic Actions
Conditioned Culture Medium
Glucagon
Mitogens
Culture Media
Insulin
Liver
Growth

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Carr, B. I., Hayashi, I., Branum, E. L., & Moses, H. L. (1986). Inhibition of DNA synthesis in rat hepatocytes by platelet-derived type β transforming growth factor. Cancer Research, 46(5), 2330-2334.

Inhibition of DNA synthesis in rat hepatocytes by platelet-derived type β transforming growth factor. / Carr, B. I.; Hayashi, I.; Branum, E. L.; Moses, H. L.

In: Cancer Research, Vol. 46, No. 5, 1986, p. 2330-2334.

Research output: Contribution to journalArticle

Carr, BI, Hayashi, I, Branum, EL & Moses, HL 1986, 'Inhibition of DNA synthesis in rat hepatocytes by platelet-derived type β transforming growth factor', Cancer Research, vol. 46, no. 5, pp. 2330-2334.
Carr, B. I. ; Hayashi, I. ; Branum, E. L. ; Moses, H. L. / Inhibition of DNA synthesis in rat hepatocytes by platelet-derived type β transforming growth factor. In: Cancer Research. 1986 ; Vol. 46, No. 5. pp. 2330-2334.
@article{9ae28244a0af4baab383fb60a327d099,
title = "Inhibition of DNA synthesis in rat hepatocytes by platelet-derived type β transforming growth factor",
abstract = "Platelet-derived type β transforming growth factor (TGFβ) is a potent inhibitor of DNA synthesis in primary monolayer cultures of adult rat hepatocytes. TGFβ induced a 50{\%} inhibition of epidermal growth factor (EGF)-mediated DNA synthesis at approximately 5 x 1012 M. This inhibition did not appear to be due to a delay in the peak of DNA synthesis or a toxic action, nor could it be overcome by increasing concentrations of the mitogens EGF, insulin, or glucagon. Inhibition was observed either when TGFβ and EGF were continuously present together in the culture medium or when TGFβ was added to the hepatocyte cultures after removal of the EGF stimulant. This observation together with a lack of an inhibitory effect of TGFβ on the binding of 125I-labeled EGF to hepatocytes in culture, suggests that the inhibitory action of TGFβ was not caused by a direct competition with EGF at the cell surface. TGFβ could not inhibit DNA synthesis once it had begun; however, the inhibitory action of TGFβ could be partially overcome by increasing amounts of conditioned medium produced by normal hepatocytes. Specific saturable receptors for TGFβ were found on the normal rat hepatocytes, but specific binding could not be detected on hepatocytes from regenerating liver. TGFβ is thus a potent inhibitor of EGF-induced DNA synthesis in adult rat hepatocytes. Its significance for growth control in vivo has yet to be assessed.",
author = "Carr, {B. I.} and I. Hayashi and Branum, {E. L.} and Moses, {H. L.}",
year = "1986",
language = "English",
volume = "46",
pages = "2330--2334",
journal = "Journal of Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "5",

}

TY - JOUR

T1 - Inhibition of DNA synthesis in rat hepatocytes by platelet-derived type β transforming growth factor

AU - Carr, B. I.

AU - Hayashi, I.

AU - Branum, E. L.

AU - Moses, H. L.

PY - 1986

Y1 - 1986

N2 - Platelet-derived type β transforming growth factor (TGFβ) is a potent inhibitor of DNA synthesis in primary monolayer cultures of adult rat hepatocytes. TGFβ induced a 50% inhibition of epidermal growth factor (EGF)-mediated DNA synthesis at approximately 5 x 1012 M. This inhibition did not appear to be due to a delay in the peak of DNA synthesis or a toxic action, nor could it be overcome by increasing concentrations of the mitogens EGF, insulin, or glucagon. Inhibition was observed either when TGFβ and EGF were continuously present together in the culture medium or when TGFβ was added to the hepatocyte cultures after removal of the EGF stimulant. This observation together with a lack of an inhibitory effect of TGFβ on the binding of 125I-labeled EGF to hepatocytes in culture, suggests that the inhibitory action of TGFβ was not caused by a direct competition with EGF at the cell surface. TGFβ could not inhibit DNA synthesis once it had begun; however, the inhibitory action of TGFβ could be partially overcome by increasing amounts of conditioned medium produced by normal hepatocytes. Specific saturable receptors for TGFβ were found on the normal rat hepatocytes, but specific binding could not be detected on hepatocytes from regenerating liver. TGFβ is thus a potent inhibitor of EGF-induced DNA synthesis in adult rat hepatocytes. Its significance for growth control in vivo has yet to be assessed.

AB - Platelet-derived type β transforming growth factor (TGFβ) is a potent inhibitor of DNA synthesis in primary monolayer cultures of adult rat hepatocytes. TGFβ induced a 50% inhibition of epidermal growth factor (EGF)-mediated DNA synthesis at approximately 5 x 1012 M. This inhibition did not appear to be due to a delay in the peak of DNA synthesis or a toxic action, nor could it be overcome by increasing concentrations of the mitogens EGF, insulin, or glucagon. Inhibition was observed either when TGFβ and EGF were continuously present together in the culture medium or when TGFβ was added to the hepatocyte cultures after removal of the EGF stimulant. This observation together with a lack of an inhibitory effect of TGFβ on the binding of 125I-labeled EGF to hepatocytes in culture, suggests that the inhibitory action of TGFβ was not caused by a direct competition with EGF at the cell surface. TGFβ could not inhibit DNA synthesis once it had begun; however, the inhibitory action of TGFβ could be partially overcome by increasing amounts of conditioned medium produced by normal hepatocytes. Specific saturable receptors for TGFβ were found on the normal rat hepatocytes, but specific binding could not be detected on hepatocytes from regenerating liver. TGFβ is thus a potent inhibitor of EGF-induced DNA synthesis in adult rat hepatocytes. Its significance for growth control in vivo has yet to be assessed.

UR - http://www.scopus.com/inward/record.url?scp=0022569829&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022569829&partnerID=8YFLogxK

M3 - Article

VL - 46

SP - 2330

EP - 2334

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0008-5472

IS - 5

ER -